These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 17975961)
1. FT-raman spectra of the border of infiltrating ductal carcinoma lesions. de Miranda Marzullo AC; Neto OP; Bitar RA; da Silva Martinho H; Martin AA Photomed Laser Surg; 2007 Oct; 25(5):455-60. PubMed ID: 17975961 [TBL] [Abstract][Full Text] [Related]
2. Raman spectroscopy of normal and diseased human breast tissues. Frank CJ; McCreery RL; Redd DC Anal Chem; 1995 Mar; 67(5):777-83. PubMed ID: 7762814 [TBL] [Abstract][Full Text] [Related]
3. [Study the Raman spectroscopy of breast tumor limbic tissue]. Zhao YL; Lü J; Ge XH; Yao SX; Liang EJ Guang Pu Xue Yu Guang Pu Fen Xi; 2006 Jul; 26(7):1267-71. PubMed ID: 17020037 [TBL] [Abstract][Full Text] [Related]
4. The lipid-reactive oxygen species phenotype of breast cancer. Raman spectroscopy and mapping, PCA and PLSDA for invasive ductal carcinoma and invasive lobular carcinoma. Molecular tumorigenic mechanisms beyond Warburg effect. Surmacki J; Brozek-Pluska B; Kordek R; Abramczyk H Analyst; 2015 Apr; 140(7):2121-33. PubMed ID: 25615557 [TBL] [Abstract][Full Text] [Related]
5. Novel chemometrics‑assisted spectroscopic methods for diagnosis and monitoring of invasive ductal carcinoma in breast tissue. Albayrak M; Senol O; Demirkaya-Miloglu F; Calik M; Kadioglu Y Bratisl Lek Listy; 2019; 120(3):184-187. PubMed ID: 31023035 [TBL] [Abstract][Full Text] [Related]
6. Resonance Raman and Raman spectroscopy for breast cancer detection. Liu CH; Zhou Y; Sun Y; Li JY; Zhou LX; Boydston-White S; Masilamani V; Zhu K; Pu Y; Alfano RR Technol Cancer Res Treat; 2013 Aug; 12(4):371-82. PubMed ID: 23448574 [TBL] [Abstract][Full Text] [Related]
7. Spectral morphometric characterization of breast carcinoma cells. Barshack I; Kopolovic J; Malik Z; Rothmann C Br J Cancer; 1999 Mar; 79(9-10):1613-9. PubMed ID: 10188915 [TBL] [Abstract][Full Text] [Related]
8. Mucinous lesions of the breast. A pathological continuum. Weaver MG; Abdul-Karim FW; al-Kaisi N Pathol Res Pract; 1993 Sep; 189(8):873-6. PubMed ID: 8302709 [TBL] [Abstract][Full Text] [Related]
9. Discrimination of non-melanoma skin lesions from non-tumor human skin tissues in vivo using Raman spectroscopy and multivariate statistics. Silveira FL; Pacheco MT; Bodanese B; Pasqualucci CA; Zângaro RA; Silveira L Lasers Surg Med; 2015 Jan; 47(1):6-16. PubMed ID: 25583686 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Yeung DK; Yang WT; Tse GM Radiology; 2002 Oct; 225(1):190-7. PubMed ID: 12355004 [TBL] [Abstract][Full Text] [Related]
11. Raman spectroscopy for early detection of laryngeal malignancy: preliminary results. Stone N; Stavroulaki P; Kendall C; Birchall M; Barr H Laryngoscope; 2000 Oct; 110(10 Pt 1):1756-63. PubMed ID: 11037840 [TBL] [Abstract][Full Text] [Related]
12. Mucinous metaplasia of breast carcinoma with macrocystic transformation resembling ovarian mucinous cystadenocarcinoma in a case of synchronous bilateral infiltrating ductal carcinoma. Lee SH; Chaung CR Pathol Int; 2008 Sep; 58(9):601-5. PubMed ID: 18801076 [TBL] [Abstract][Full Text] [Related]
13. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207 [TBL] [Abstract][Full Text] [Related]
14. Studying the pathological and biochemical features in breast cancer progression by confocal Raman microspectral imaging of excised tissue samples. Wang S; Li H; Ren Y; Yu F; Song D; Zhu L; Yu S; Jiang S; Zeng H J Photochem Photobiol B; 2021 Sep; 222():112280. PubMed ID: 34375907 [TBL] [Abstract][Full Text] [Related]
15. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525 [TBL] [Abstract][Full Text] [Related]
16. SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma. Hsiao YH; Lien HC; Hwa HL; Kuo WH; Chang KJ; Hsieh FJ Breast J; 2010; 16(3):305-8. PubMed ID: 20210803 [TBL] [Abstract][Full Text] [Related]
17. [Expression of alpha-tubulin and gamma-tubulin in premalignant lesion and carcinoma of breast and the significance thereof]. Niu Y; Wang Y; Yu Y; Ding XM; Lü SH; Xiao XQ Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):56-60. PubMed ID: 16606540 [TBL] [Abstract][Full Text] [Related]
18. Exploring type II microcalcifications in benign and premalignant breast lesions by shell-isolated nanoparticle-enhanced Raman spectroscopy (SHINERS). Liang L; Zheng C; Zhang H; Xu S; Zhang Z; Hu C; Bi L; Fan Z; Han B; Xu W Spectrochim Acta A Mol Biomol Spectrosc; 2014 Nov; 132():397-402. PubMed ID: 24887501 [TBL] [Abstract][Full Text] [Related]
19. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Moll R; Mitze M; Frixen UH; Birchmeier W Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859 [TBL] [Abstract][Full Text] [Related]
20. Biochemical correlation of Raman spectra of normal, benign and malignant breast tissues: a spectral deconvolution study. Chowdary MV; Kalyan Kumar K; Mathew S; Rao L; Krishna CM; Kurien J Biopolymers; 2009 Jul; 91(7):539-46. PubMed ID: 19226625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]